Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status. (2021)
Attributed to:
Structural Studies on Viruses, Viral Proteins and Cell Interactions
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.cmi.2021.05.041
PubMed Identifier: 34111577
Publication URI: http://europepmc.org/abstract/MED/34111577
Type: Journal Article/Review
Volume: 27
Parent Publication: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Issue: 10
ISSN: 1198-743X